Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen

References

• Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer 2012; 12:278-87; PMID:22437872; http://dx.doi.org/10.1038/nrc3236
   PubMed Web of Science ®Google Scholar
• Vacchelli E, Eggermont A, Galon J, Sautes-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: monoclonal antibodies in cancer therapy. Oncoimmunology 2013; 2:e22789; PMID:23482847; http://dx.doi.org/10.4161/onci.22789
   PubMed Web of Science ®Google Scholar
• Govindan SV, Goldenberg DM. Designing immunoconjugates for cancer therapy. Expert Opin Biol Ther 2012; 12:873-90; PMID:22679911; http://dx.doi.org/10.1517/14712598.2012.685153
   PubMed Web of Science ®Google Scholar
• Perez HL, Cardarelli PM, Deshpande S, Gangwar S, Schroeder GM, Vite GD, Borzilleri RM. Antibody-drug conjugates: current status and future directions. Drug Discov Today 2014; 19:869-81; PMID:24239727; http://dx.doi.org/10.1016/j.drudis.2013.11.004
   PubMed Web of Science ®Google Scholar
• Chari RV. Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res 2008; 41:98-107; PMID:17705444; http://dx.doi.org/10.1021/ar700108g
   PubMed Web of Science ®Google Scholar
• Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol 2004; 5:121-32; PMID:15040445; http://dx.doi.org/10.1038/nrm1315
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 2007; 59:748-58; PMID:17659804; http://dx.doi.org/10.1016/j.addr.2007.06.008
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Etrych T, Chytil P, Pechar M, Jelinkova M, Rihova B. Polymeric anticancer drugs with pH-controlled activation. Int J Pharm 2004; 277:63-72; PMID:15158969; http://dx.doi.org/10.1016/j.ijpharm.2003.02.001
   PubMed Web of Science ®Google Scholar
• Doronina SO, Mendelsohn BA, Bovee TD, Cerveny CG, Alley SC, Meyer DL, Oflazoglu E, Toki BE, Sanderson RJ, Zabinski RF et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem 2006; 17:114-24; PMID:16417259; http://dx.doi.org/10.1021/bc0502917
   PubMed Web of Science ®Google Scholar
• Ju T, Otto VI, Cummings RD. The Tn antigen-structural simplicity and biological complexity. Angew Chem Int Ed Engl 2011; 50:1770-91; PMID:21259410; http://dx.doi.org/10.1002/anie.201002313
   PubMed Web of Science ®Google Scholar
• Springer GF. T and Tn, general carcinoma autoantigens. Science 1984; 224:1198-206; PMID:6729450; http://dx.doi.org/10.1126/science.6729450
   PubMed Web of Science ®Google Scholar
• Beuzelin-Yvraut M, Bourguignat A, Phillips E, Roseto A, Osinaga E. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein. J Clin Pathol 1995; 48:433-7; PMID:7629290; http://dx.doi.org/10.1136/jcp.48.5.433
   PubMed Web of Science ®Google Scholar
• Croce MV, Rabassa ME, Price MR, Segal-Eiras A. MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma. Pathol Oncol Res 2001; 7:284-91; PMID:11882908; http://dx.doi.org/10.1007/BF03032385
   PubMedGoogle Scholar
• Hubert P, Heitzmann A, Viel S, Nicolas A, Sastre-Garau X, Oppezzo P, Pritsch O, Osinaga E, Amigorena S. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy. Cancer Res 2011; 71:5134-43; PMID:21697279; http://dx.doi.org/10.1158/0008-5472.CAN-10-4222
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989; 49:197-204; PMID:2908846
   PubMed Web of Science ®Google Scholar
• Li Q, Anver MR, Butcher DO, Gildersleeve JC. Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines. Mol Cancer Ther 2009; 8:971-9; PMID:19372570; http://dx.doi.org/10.1158/1535-7163.MCT-08-0934
   PubMed Web of Science ®Google Scholar
• Pancino GF, Osinaga E, Vorauher W, Kakouche A, Mistro D, Charpin C, Roseto A. Production of a monoclonal antibody as immunohistochemical marker on paraffin embedded tissues using a new immunization method. Hybridoma 1990; 9:389-95; PMID:2210779; http://dx.doi.org/10.1089/hyb.1990.9.389
   PubMedGoogle Scholar
• Danussi C, Coslovi A, Campa C, Mucignat MT, Spessotto P, Uggeri F, Paoletti S, Colombatti A. A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction. Glycobiology 2009; 19:1056-67; PMID:19528665; http://dx.doi.org/10.1093/glycob/cwp085
   PubMed Web of Science ®Google Scholar
• Ando H, Matsushita T, Wakitani M, Sato T, Kodama-Nishida S, Shibata K, Shitara K, Ohta S. Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo. Biol Pharm Bull 2008; 31:1739-44; PMID:18758069; http://dx.doi.org/10.1248/bpb.31.1739
   PubMed Web of Science ®Google Scholar
• Avichezer D, Springer GF, Schechter B, Arnon R. Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model. Int J Cancer J Int Du Cancer 1997; 72:119-27; PMID:9212232; http://dx.doi.org/10.1002/(SICI)1097-0215(19970703)72:1<119::AID-IJC17>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Nakada H, Inoue M, Numata Y, Tanaka N, Funakoshi I, Fukui S, Mellors A, Yamashina I. Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128). Proc Natl Acad Sci USA 1993; 90:2495-9; PMID:7681597; http://dx.doi.org/10.1073/pnas.90.6.2495
   PubMed Web of Science ®Google Scholar
• Oppezzo P, Osinaga E, Tello D, Bay S, Cantacuzene D, Irigoin F, Ferreira A, Roseto A, Cayota A, Alzari P et al. Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen. Hybridoma 2000; 19:229-39; PMID:10952411; http://dx.doi.org/10.1089/02724570050109620
   PubMedGoogle Scholar
• Welinder C, Baldetorp B, Borrebaeck C, Fredlund BM, Jansson B. A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity. Glycobiol 2011; 21:1097-107; PMID:21470982; http://dx.doi.org/10.1093/glycob/cwr048
   PubMed Web of Science ®Google Scholar
• Aller CT, Kucuk O, Springer GF, Gilman-Sachs A. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells. Am J Hematol 1996; 52:29-38; PMID:8638608; http://dx.doi.org/10.1002/(SICI)1096-8652(199605)52:1<29::AID-AJH5>3.0.CO;2-8
   PubMed Web of Science ®Google Scholar
• Inoue M, Nakada H, Tanaka N, Yamashina I. Tn antigen is expressed on leukosialin from T-lymphoid cells. Cancer Res 1994; 54:85-8; PMID:8261467
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Marafioti T, Hatton CS, Dirnhofer S, Roncador G, Went P, Tzankov A, Pileri SA, Pulford K, Banham AH. Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling. Int J Cancer J Int Du Cancer 2006; 118:3161-6; PMID:16395706; http://dx.doi.org/10.1002/ijc.21762
   PubMed Web of Science ®Google Scholar
• Asundi J, Reed C, Arca J, McCutcheon K, Ferrando R, Clark S, Luis E, Tien J, Firestein R, Polakis P. An antibody-drug conjugate targeting the endothelin B receptor for the treatment of melanoma. Clin Cancer Res 2011; 17:965-75; PMID:21245091; http://dx.doi.org/10.1158/1078-0432.CCR-10-2340
   PubMed Web of Science ®Google Scholar
• Chen Y, Clark S, Wong T, Chen Y, Chen Y, Dennis MS, Luis E, Zhong F, Bheddah S, Koeppen H et al. Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models. Cancer Res 2007; 67:4924-32; PMID:17510422; http://dx.doi.org/10.1158/0008-5472.CAN-06-4512
   PubMed Web of Science ®Google Scholar
• Ryan MC, Kostner H, Gordon KA, Duniho S, Sutherland MK, Yu C, Kim KM, Nesterova A, Anderson M, McEarchern JA et al. Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75. Br J Cancer 2010; 103:676-84; PMID:20664585; http://dx.doi.org/10.1038/sj.bjc.6605816
   PubMed Web of Science ®Google Scholar
• Grant BD, Donaldson JG. Pathways and mechanisms of endocytic recycling. Nat Rev Mol Cell Biol 2009; 10:597-608; PMID:19696797; http://dx.doi.org/10.1038/nrm2755
   PubMed Web of Science ®Google Scholar
• Endo Y, Mitsui K, Motizuki M, Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem 1987; 262:5908-12; PMID:3571242
   PubMed Web of Science ®Google Scholar
• Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ. Immunotoxin therapy of cancer. Nat Rev Cancer 2006; 6:559-65; PMID:16794638; http://dx.doi.org/10.1038/nrc1891
   PubMed Web of Science ®Google Scholar
• Oflazoglu E, Stone IJ, Gordon K, Wood CG, Repasky EA, Grewal IS, Law CL, Gerber HP. Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker. Clin Cancer Res 2008; 14:6171-80; PMID:18809969; http://dx.doi.org/10.1158/1078-0432.CCR-08-0916
   PubMed Web of Science ®Google Scholar
• Doronina SO, Bovee TD, Meyer DW, Miyamoto JB, Anderson ME, Morris-Tilden CA, Senter PD. Novel peptide linkers for highly potent antibody-auristatin conjugate. Bioconjug Chem 2008; 19:1960-3; PMID:18803412; http://dx.doi.org/10.1021/bc800289a
   PubMed Web of Science ®Google Scholar
• Mazal D, Lo-Man R, Bay S, Pritsch O, Deriaud E, Ganneau C, Medeiros A, Ubillos L, Obal G, Berois N et al. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer. Cancer Immunol Immunother 2013; 62:1107-22; PMID:23604173; http://dx.doi.org/10.1007/s00262-013-1425-7
   PubMed Web of Science ®Google Scholar
• Charpin C, Pancino G, Osinaga E, Bonnier P, Lavaut MN, Allasia C, Roseto A. Monoclonal antibody 83D4 immunoreactivity in human tissues: cellular distribution and microcytophotometric analysis of immunoprecipitates on tissue sections. Anticancer Res 1992; 12:209-23; PMID:1567169
   PubMed Web of Science ®Google Scholar
• Osinaga E, Bay S, Tello D, Babino A, Pritsch O, Assemat K, Cantacuzene D, Nakada H, Alzari P. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy. FEBS Lett 2000; 469:24-8; PMID:10708749; http://dx.doi.org/10.1016/S0014-5793(00)01248-5
   PubMed Web of Science ®Google Scholar
• Rudnick SI, Lou J, Shaller CC, Tang Y, Klein-Szanto AJ, Weiner LM, Marks JD, Adams GP. Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors. Cancer Res 2011; 71:2250-9; PMID:21406401; http://dx.doi.org/10.1158/0008-5472.CAN-10-2277
   PubMed Web of Science ®Google Scholar
• Lim SH, Vaughan AT, Ashton-Key M, Williams EL, Dixon SV, Chan HT, Beers SA, French RR, Cox KL, Davies AJ et al. Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy. Blood 2011; 118:2530-40; PMID:21768293; http://dx.doi.org/10.1182/blood-2011-01-330357
   PubMed Web of Science ®Google Scholar
• Austin CD, De Maziere AM, Pisacane PI, van Dijk SM, Eigenbrot C, Sliwkowski MX, Klumperman J, Scheller RH. Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin. Mol Biol Cell 2004; 15:5268-82; PMID:15385631; http://dx.doi.org/10.1091/mbc.E04-07-0591
   PubMed Web of Science ®Google Scholar
• Iglesias-Bartolome R, Crespo PM, Gomez GA, Daniotti JL. The antibody to GD3 ganglioside, R24, is rapidly endocytosed and recycled to the plasma membrane via the endocytic recycling compartment. Inhibitory effect of brefeldin A and monensin. FEBS J 2006; 273:1744-58; PMID:16623710; http://dx.doi.org/10.1111/j.1742-4658.2006.05194.x
   PubMed Web of Science ®Google Scholar
• Perera RM, Zoncu R, Johns TG, Pypaert M, Lee FT, Mellman I, Old LJ, Toomre DK, Scott AM. Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody. Neoplasia 2007; 9:1099-110; PMID:18084617; http://dx.doi.org/10.1593/neo.07721
   PubMed Web of Science ®Google Scholar
• Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, DeBlanc RL, Gearing RP, Bovee TD, Siegall CB et al. Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nat Biotechnol 2003; 21:778-84; PMID:12778055; http://dx.doi.org/10.1038/nbt832
   PubMed Web of Science ®Google Scholar
• Jackson D, Gooya J, Mao S, Kinneer K, Xu L, Camara M, Fazenbaker C, Fleming R, Swamynathan S, Meyer D et al. A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo. Cancer Res 2008; 68:9367-74; PMID:19010911; http://dx.doi.org/10.1158/0008-5472.CAN-08-1933
   PubMed Web of Science ®Google Scholar
• Polito L, Bortolotti M, Pedrazzi M, Bolognesi A. Immunotoxins and other conjugates containing saporin-s6 for cancer therapy. Toxins (Basel) 2011; 3:697-720; PMID:22069735; http://dx.doi.org/10.3390/toxins3060697
   PubMed Web of Science ®Google Scholar
• Hamblett KJ, Senter PD, Chace DF, Sun MM, Lenox J, Cerveny CG, Kissler KM, Bernhardt SX, Kopcha AK, Zabinski RF et al. Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin Cancer Res 2004; 10:7063-70; PMID:15501986; http://dx.doi.org/10.1158/1078-0432.CCR-04-0789
   PubMed Web of Science ®Google Scholar
• Bouchard H, Viskov C, Garcia-Echeverria C. Antibody-drug conjugates–a new wave of cancer drugs. Bioorg Med Chem Lett 2014; 24:5357-63; PMID:25455482; http://dx.doi.org/10.1016/j.bmcl.2014.10.021
   PubMed Web of Science ®Google Scholar
• Fodstad O, Aamdal S, McMenamin M, Nesland JM, Pihl A. A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX. Int J Cancer J Int Du Cancer 1988; 41:442-9; PMID:3346110; http://dx.doi.org/10.1002/ijc.2910410322
   PubMed Web of Science ®Google Scholar